Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation Study

阿米卡星 医学 药代动力学 人口 肾功能 加药 药效学 药理学 非金属 内科学 抗生素 生物 微生物学 环境卫生
作者
Nada Dia,Sabrina De Winter,Matthias Gijsen,Stefanie Desmet,Peter Vanbrabant,Willy Peetermans,Isabel Spriet,Erwin Dreesen
出处
期刊:Therapeutic Drug Monitoring [Lippincott Williams & Wilkins]
卷期号:47 (3): 353-362
标识
DOI:10.1097/ftd.0000000000001279
摘要

Background: In adult patients with sepsis or septic shock admitted to the emergency department, a single intravenous 15 mg/kg amikacin dose provides inadequate pharmacokinetic–pharmacodynamic target attainment at the locally reported minimum inhibitory concentration (MIC) of 2 mg/L and the European Committee on Antimicrobial Susceptibility Testing clinical breakpoint for Enterobacterales of 8 mg/L. Objectives: To provide an amikacin dosing strategy with a clinically acceptable probability of target attainment (PTA) for all patients. Methods: Stochastic simulations were performed using a two-compartment population pharmacokinetics model of amikacin (NONMEM 7.5). PTA was evaluated for various dosing strategies across a range of virtual patients' body weight, body mass index, serum total protein, serum sodium, fluid balance, and estimated glomerular filtration rate according to the Chronic Kidney Disease Epidemiology Collaboration equation (eGFR CKD-EPI ), at the locally reported MIC of 2 mg/L and the clinical breakpoint of 8 mg/L. The pharmacokinetic–pharmacodynamic targets were a 24-hour area under the concentration–time curve (AUC 24h )/MIC of ≥80 and a 24-hour postdose concentration (C 24h ) of < 3 mg/L for efficacy and safety, respectively. Results: The PTA for the clinical breakpoint of 8 mg/L was <90% with standard 15 mg/kg dosing, across all patient characteristics. A flat 1500-mg dose achieved ≥90% PTA for the entire population at a MIC of 2 mg/L. However, at the clinical breakpoint of 8 mg/L, a flat 3500-mg dose provided ≥90% PTA only when the eGFR CKD-EPI was <96 mL/min/1.73 m 2 . The C 24h was similar for 1500 mg and 15 mg/kg dosing, whereas 3500 mg resulted in a higher C 24h . Conclusions: A flat dose is recommended over weight-based dosing. However, selecting a 1500-mg or 3500-mg dose may compromise either efficacy (MIC 2 mg/L) or safety (clinical breakpoint 8 mg/L), posing a dilemma. Clinical validation is warranted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
皮皮发布了新的文献求助10
1秒前
传奇3的应助被科研通管家采纳,获得10
3秒前
爆米花的应助被科研通管家采纳,获得10
3秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
3秒前
脑洞疼的应助被科研通管家采纳,获得10
4秒前
充电宝的应助被科研通管家采纳,获得10
4秒前
传奇3的应助被科研通管家采纳,获得10
4秒前
丘比特的应助被橙c美式采纳,获得10
4秒前
Orange的应助被科研通管家采纳,获得10
4秒前
wanci的应助被科研通管家采纳,获得10
4秒前
北雨发布了新的文献求助20
4秒前
Jasper的应助被科研通管家采纳,获得10
4秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
4秒前
Ava的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
orixero的应助被科研通管家采纳,获得10
5秒前
5秒前
小二郎的应助被科研通管家采纳,获得10
5秒前
科目三的应助被科研通管家采纳,获得10
5秒前
Lucas的应助被科研通管家采纳,获得10
5秒前
足球完成签到,获得积分10
5秒前
6秒前
zisle完成签到,获得积分10
6秒前
6秒前
7秒前
Ah发布了新的文献求助10
7秒前
大模型的应助被chen采纳,获得10
7秒前
7秒前
8秒前
8秒前
8秒前
memaclee完成签到,获得积分10
9秒前
NexusExplorer的应助被zhou周周周采纳,获得10
9秒前
10秒前
小马甲的应助被Huttu采纳,获得10
10秒前
科研通AI6.4的应助被yxy采纳,获得10
11秒前
zz发布了新的文献求助10
11秒前
hgc完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Nanocomposite Removal of Pesticides from Wastewater 1000
Practical Manual of Forensic Psychophysiology: Methodology, Execution, and Fields of Application 800
Rosenblum, Global Change Biology 800
Final Report for the 2-D Test of Model 901 Rotor and Wing Airfoils (BSWT 592) 528
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 物理 生物化学 化学工程 内科学 复合材料 催化作用 心理学 人工智能 细胞生物学 光电子学 无机化学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 7905863
求助须知:如何正确求助?哪些是违规求助? 9410823
关于积分的说明 20890247
捐赠科研通 7507181
什么是DOI,文献DOI怎么找? 3361585
关于科研通互助平台的介绍 2499677
邀请新用户注册赠送积分活动 2391884